THC tests don’t actually detect THC itself in most cases. The most common version, the urine test, looks for a byproduct your body creates after breaking down THC: a metabolite called THC-COOH. This distinction matters because it means a positive urine test tells you someone consumed cannabis at some point in the past, not that they’re currently impaired. Different test types (urine, blood, saliva, hair) each work through different mechanisms and detect cannabis use over very different time windows.
What Urine Tests Actually Measure
When you consume cannabis, your liver converts delta-9-THC into several metabolites. The one that matters for testing is THC-COOH, a fat-soluble compound your kidneys gradually filter into urine. Urine tests are designed to detect this specific metabolite, not THC itself, not CBD, and not synthetic cannabinoids.
The process works in two stages. First, a quick screening test called an immunoassay reacts to THC-COOH in the sample. Think of it as a broad net: the test uses antibodies that bind to the metabolite, and if enough binding occurs, the result reads positive. The federal cutoff for this initial screen is 50 ng/mL, meaning the metabolite concentration must exceed that threshold to trigger a positive result.
If the initial screen comes back positive, a second, more precise test confirms the result. This confirmation step uses a technology called gas chromatography-mass spectrometry (or a similar method) that can identify the exact molecules in the sample with high accuracy. The confirmation cutoff is lower: 15 ng/mL. This two-step process exists because the initial immunoassay screen can sometimes react to substances that aren’t THC-COOH, producing false positives. The confirmation test eliminates those errors.
Why Detection Windows Vary So Much
THC-COOH is fat-soluble, which means your body stores it in fat tissue rather than flushing it quickly. After you consume cannabis, THC rapidly moves from your blood into fat deposits throughout the body. It then slowly leaks back into the bloodstream over days or weeks, gets processed by the liver again, and eventually exits through urine.
For someone who uses cannabis once or occasionally, urine tests typically detect THC-COOH for up to 4 days after use at the 15 ng/mL cutoff. For frequent, heavy users, the picture is dramatically different. Studies of chronic users during monitored abstinence found detectable THC metabolites for weeks. In one study, some participants still had measurable levels 24 days after their last use, with a median detection time of about 7 days even using a more sensitive cutoff. The range stretched from 3 to 25 days depending on the individual.
This wide range comes down to how much THC has accumulated in your fat stores over time. A daily user builds up a reservoir that takes far longer to drain than someone who took a single hit at a party.
How Body Fat Affects Your Results
Because THC binds to fat cells, your body composition directly influences how long you’ll test positive. People with higher body fat percentages have more storage capacity for THC metabolites, which means a longer, slower release back into the bloodstream.
What’s particularly interesting is that anything triggering your body to burn fat can temporarily spike THC-COOH levels in your blood and urine. Research in the British Journal of Pharmacology demonstrated that both food deprivation and stress hormones significantly increased blood concentrations of THC and THC-COOH in subjects who hadn’t used cannabis recently. When fat cells break down their stored triglycerides for energy, the THC trapped inside gets released back into circulation. Intense exercise, crash dieting, or high stress before a test could, in theory, push metabolite levels above the detection threshold even if they were trending downward.
How Blood Tests Differ
Blood tests look for delta-9-THC itself, not just its metabolites. This makes them a better indicator of recent use. After smoking, THC concentrations in blood peak immediately and drop to roughly 2 ng/mL within 4 to 6 hours. The metabolite THC-COOH appears in blood within minutes and lingers considerably longer than THC itself, but the primary target for blood testing is the parent compound.
Because of this short window, blood tests are most commonly used in situations where recent impairment matters, like traffic stops or accident investigations. They’re far less useful for workplace screening, where the question is typically whether someone has used cannabis at all in recent weeks.
Oral Fluid (Saliva) Testing
Saliva tests detect delta-9-THC directly, similar to blood tests, making them another tool for identifying recent use rather than past exposure. The federal workplace cutoff for oral fluid is 4 ng/mL on the initial screen, dropping to 2 ng/mL for confirmation. These are based on undiluted saliva samples.
Detection windows for saliva are relatively short, generally ranging from several hours to about a day after use, depending on the dose and frequency of use. Saliva testing has gained traction for roadside drug checks and workplace programs because collection is simple, hard to tamper with, and doesn’t require a bathroom. Federal guidelines updated in 2025 formally authorize oral fluid as an option for federal workplace drug testing alongside urine.
Hair Follicle Tests and Long-Term Detection
Hair testing works on a completely different principle. As THC circulates in your blood, small amounts get incorporated into hair follicles as new hair grows. The amount that ends up in hair depends on how long THC was available in the bloodstream and, to some extent, on hair pigment, though this factor is less significant for cannabinoids than for other drugs.
Because head hair grows at roughly half an inch per month, a standard 1.5-inch hair sample covers approximately 90 days of use. Some programs request longer samples covering six months or even a full year. Hair tests are generally used when long-term abstinence needs to be verified, such as in custody disputes or certain professional licensing situations. They’re less useful for detecting a single instance of use because the amount of THC deposited from one exposure may not reach detectable levels.
False Positives and Cross-Reactivity
The initial immunoassay screen is the weak link in the testing chain. Its antibodies can occasionally bind to molecules that look structurally similar to THC-COOH, producing a false positive. Common culprits include ibuprofen, naproxen, and the heartburn medication pantoprazole. This is precisely why confirmation testing exists: the more precise second test can distinguish THC-COOH from these lookalike molecules.
CBD products present a different kind of risk. Pure CBD does not typically cross-react with THC immunoassays. However, cannabinol (CBN), a compound found in aged cannabis and some full-spectrum CBD products, has been shown to cross-react with at least two commercial THC immunoassays. More practically, many CBD products labeled “THC-free” contain trace amounts of THC that can accumulate with regular use. Full-spectrum CBD products legally contain up to 0.3% THC, and daily use of these products has pushed some people above the 50 ng/mL screening threshold.
What These Tests Can and Cannot Tell You
A positive urine test confirms that THC entered your body at some point before the sample was collected. It cannot tell you when the person last used cannabis, how much they consumed, or whether they were impaired at the time of collection. The American College of Medical Toxicology has stated clearly that urine THC metabolite tests are not designed to determine clinical impairment.
Blood and saliva tests come closer to indicating recent use because they detect THC itself and have much shorter detection windows. But even these can’t establish a direct link between a THC concentration and a specific level of impairment the way a blood alcohol level can. THC affects individuals differently based on tolerance, and heavy users can have measurable blood THC levels even during periods of abstinence due to slow release from fat stores.